WO1991001965A1 - Procede de fractionnement d'un melange d'esters d'acides gras - Google Patents
Procede de fractionnement d'un melange d'esters d'acides gras Download PDFInfo
- Publication number
- WO1991001965A1 WO1991001965A1 PCT/FR1990/000548 FR9000548W WO9101965A1 WO 1991001965 A1 WO1991001965 A1 WO 1991001965A1 FR 9000548 W FR9000548 W FR 9000548W WO 9101965 A1 WO9101965 A1 WO 9101965A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- esters
- mixture
- solvent
- resin
- bed
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 230000008569 process Effects 0.000 title claims abstract description 44
- -1 fatty acid esters Chemical class 0.000 title claims abstract description 23
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 19
- 229930195729 fatty acid Natural products 0.000 title claims abstract description 19
- 239000000194 fatty acid Substances 0.000 title claims abstract description 19
- 150000002148 esters Chemical class 0.000 claims abstract description 96
- 239000011347 resin Substances 0.000 claims abstract description 73
- 229920005989 resin Polymers 0.000 claims abstract description 73
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 57
- 239000002904 solvent Substances 0.000 claims abstract description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 51
- 239000012156 elution solvent Substances 0.000 claims abstract description 24
- 239000003921 oil Substances 0.000 claims abstract description 18
- 229940040452 linolenate Drugs 0.000 claims abstract description 14
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 13
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 claims abstract description 12
- 229940049918 linoleate Drugs 0.000 claims abstract description 12
- 239000002253 acid Substances 0.000 claims abstract description 9
- DTOSIQBPPRVQHS-PDBXOOCHSA-M linolenate Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC([O-])=O DTOSIQBPPRVQHS-PDBXOOCHSA-M 0.000 claims abstract description 9
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003456 ion exchange resin Substances 0.000 claims abstract description 8
- 229920003303 ion-exchange polymer Polymers 0.000 claims abstract description 8
- 238000001704 evaporation Methods 0.000 claims abstract description 5
- 241001072256 Boraginaceae Species 0.000 claims abstract description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- 235000019198 oils Nutrition 0.000 claims description 17
- 238000005194 fractionation Methods 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims description 7
- 239000004165 Methyl ester of fatty acids Substances 0.000 claims description 7
- 235000019387 fatty acid methyl ester Nutrition 0.000 claims description 7
- 150000002500 ions Chemical class 0.000 claims description 5
- 125000004067 aliphatic alkene group Chemical group 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 235000021324 borage oil Nutrition 0.000 claims description 4
- 230000008020 evaporation Effects 0.000 claims description 4
- 235000008524 evening primrose extract Nutrition 0.000 claims description 4
- 229940089020 evening primrose oil Drugs 0.000 claims description 4
- 239000010475 evening primrose oil Substances 0.000 claims description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 4
- 102100025027 E3 ubiquitin-protein ligase TRIM69 Human genes 0.000 claims description 3
- 101000830203 Homo sapiens E3 ubiquitin-protein ligase TRIM69 Proteins 0.000 claims description 3
- 239000010775 animal oil Substances 0.000 claims description 3
- 238000006386 neutralization reaction Methods 0.000 claims description 3
- 238000005809 transesterification reaction Methods 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 235000013311 vegetables Nutrition 0.000 claims description 3
- 230000008030 elimination Effects 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000005325 percolation Methods 0.000 claims description 2
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 16
- 150000004702 methyl esters Chemical class 0.000 abstract description 4
- 235000007689 Borago officinalis Nutrition 0.000 abstract 1
- 241000283075 Equus hemionus Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 150000001336 alkenes Chemical class 0.000 abstract 1
- 150000001345 alkine derivatives Chemical class 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 150000002825 nitriles Chemical class 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- 238000010828 elution Methods 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- 239000004332 silver Substances 0.000 description 5
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- 238000010908 decantation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 4
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 4
- 235000003441 saturated fatty acids Nutrition 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 241000894007 species Species 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229910002651 NO3 Inorganic materials 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- 229940049964 oleate Drugs 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000004452 microanalysis Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- GPUADMRJQVPIAS-QCVDVZFFSA-M cerivastatin sodium Chemical compound [Na+].COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 GPUADMRJQVPIAS-QCVDVZFFSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/58—Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
- C07C69/58—Esters of straight chain acids with eighteen carbon atoms in the acid moiety
Definitions
- the invention relates to a process for fractionating a mixture of fatty acid esters in order to separate the esters having different degrees of unsaturation, in order to obtain either fractions enriched with specific esters or pure esters.
- the invention can in particular be applied to fractionate a mixture of methyl esters of fatty acids, rich in linoleate and in linolenate in order to separate these esters from other fatty acid esters.
- fatty acids are very rare natural compounds in the free state, which are interesting because of their biological properties (precursors of certain molecules essential to the functioning of living organisms such as pros t aglandin; constituents of lipids) , cosmetical (promoting membrane permeability at the cutaneous level), electronic (biosensors) ... These fatty acids have the defect of being unstable, their degradation by oxidation being all the more accentuated as the degree of unsaturation is high. Currently, these fatty acids are very expensive compounds.
- silica impregnated with silver was used to effect this fractionation (US Patent No. 3,405,151); however, this process has major drawbacks residing in the significant leakage of silver and in the impossibility of recycling the silica gel.
- An improvement to this process consists in using an alumina and silver silica gel, which limits the leakage of silver, but the silica gel remains non-recyclable (US Patent No. 4,282,164).
- these silica gel processes do not allow the esters to be isolated in order to obtain pure bodies with satisfactory yield.
- US No. 4,189,442 a process for fractionating a mixture of fatty acid esters, consisting in diluting the mixture to be fractionated in a solvent based on ethyl acetate and hexane and passing this solution through several beds of highly acidic ion exchange resin, permuted in the form Ag + and Na + , these passages being carried out hot (from 50 ° C to 80 ° C) and at relatively high pressure (from 2 to 8 bars) .
- the successive resin beds, crossed by the solution, have different Ag + / Na + permutation percentages, increasing in Ag + from the first beds to the last.
- the first beds preferentially retain highly unsaturated esters (di-unsaturated, tri-unsaturated), while the other beds preferentially retain ono-unsaturated esters; saturated esters are found at the end of elution in the solution.
- This preferential retention which is a function of the percentage of permutation, comes from the different fixing properties of the various esters on the Ag + ion: for example, the highly uns ⁇ tured esters are more fixed on the first beds (with a low percentage of Ag + ) than the other esters, due to their strongest tendencies to complex with the Ag + ion.
- the esters fixed on the various beds are then collected, eluting them using a solvent based on ethyl acetate and hexane, the proportions of which are adjusted to the bed concerned.
- One objective is to provide a process benefiting from a very simplified implementation and much milder temperature and pressure conditions than those of the aforementioned process of the same type.
- Another object of the invention is to allow the production of pure polysunsaturated esters with a quasi-quantitative yield.
- Another objective is to provide a process which preserves the quality of the resins and allows long lifetimes thereof.
- Another objective is to allow a fractionation of crude vegetable or animal oil, directly after neutralization and transesterification.
- the process targeted by the invention for fractionating a mixture of fatty acid esters with a view to separating the esters having different degrees of unsaturation is of the type consisting in bringing the mixture into contact with a bed of strongly acid ion exchange resin, permuted in Ag + form, to cause solvents to percolate through the bed, and to recover by extraction the esters entrained by said solvents;
- the process according to the present invention is characterized in that:
- the mixture of esters in the absence of solvent is brought into direct contact with the ion exchange resin bed, so as to deposit said mixture inside said resin bed,
- a methanol-based solvent is then caused to percolate the resin bed, in order to elute the saturated and monounsaturated esters,
- final elution solvent comprising an aliphatic nitrile or an aliphatic alkene or an aliphatic alkyne, with double or triple terminal bond
- said final elution solvent is caused to percolate the bed resin, in order to unhook and elute the remaining esters with a degree of unsaturation greater than one
- Such a process makes it possible to separate the saturated and mono-unsaturated esters on the one hand, from the di and tri-unsaturated esters on the other hand. If it is desired to separate the di and tri-ins ⁇ tured esters, an additional step is added before the final elution, consisting in causing an ethanol-based solvent to percolate the resin bed in order to unhook and elute said said di-unsaturated esters.
- the method of the invention uses a single resin bed inside which the mixture to be fractionated is deposited. It is by successive elutions using specific solvents that the esters are then detached, species by species, according to their degree of unsaturation.
- the process of the invention therefore benefits from a very simplified implementation compared to the process of the aforementioned US Patent No. 4,189,442, since the resin bed is unique and the separation is carried out by successive elutions of setting easy work.
- the method makes it possible, if desired (ethanol step), to separate the di-unsaturated esters and the tr i-unsaturated esters, which is not the case with the US process mentioned above. This possibility is an essential practical advantage since, in most applications, pure products are needed.
- the process of the invention thus makes it possible to obtain pure di and tri-unsaturated esters at costs much lower than their current costs.
- a strong macroporous acid resin with a polystyrene backbone is used.
- this resin is preferably permuted to 100% in Ag + form, by prior percolation of a silver nitrate solution in excess s toech iom and r ique with respect to the sulfonic sites of the resin.
- the mixture of esters is brought into contact with the resin bed by pouring said mixture at the head of the resin bed so that the volume of mixture poured is at most equal to l / 15th of the total volume of the resin bed.
- This relative proportion avoids saturation of the bed which could cause losses in non-fixed esters. It should be emphasized that this limit is not restrictive compared to conventional methods, which generally require much larger volumes of resins, based on the volumes of esters treated.
- the latter is advantageously constituted by a mixture of acetoni tri le and of a carrier solvent with a lower boiling point. at 70 ° C., capable of generating an azeotropic elimination of the acetone during the extraction of the esters.
- this carrier solvent can be trich 1 or q - 1, 1, 2 trif 1 or o - 2, 2, 1 ethane, in which it is rare.
- a mixture of volume proportion of between 5% and 15% acetonitrile relative to 1,1,2,2-trichloro-2,2,1 ethane trichloro gives good results (complete desorption of esters with degree of unsaturation greater than 2 ; easy removal of the solvent). If necessary, hexane can also be used as carrier solvent.
- Esters eluted by solvents are preferably extracted by evaporation from the bed resin. This process is inexpensive to carry out and allows complete and easy extraction of the esters, taking into account the significant difference in the boiling points of the esters and of the solvents used.
- the method of the invention is particularly applicable for fractionating a mixture of methyl esters of fatty acids rich in linoleate and in linolenate, originating from a crude vegetable or animal oil having undergone neutralization and transesterification.
- This process makes it possible to separate the linoleate (di-unsaturated ester) and the linolenate (t-i-unsaturated ester) and to obtain them pure.
- These compounds have important applications in cosmetology, dietetics, lipochemistry, and their separation by physicochemical route has never been obtained to the knowledge of the inventors.
- the process can in particular be applied to a borage or evening primrose oil in order to separate the Jlinolenate contained in these oils.
- This compound is an essential chemical mediator of living organisms (precursor of prostagl ⁇ ndins) and has considerable applications in dietetic pharmacy.
- the process can also be applied to a pastel or sysimbre oil "in order to separate the o ⁇ linolenate contained in these oils.
- this compound is an essential chemical mediator and has interesting applications in dietetic pharmacy.
- This installation comprises a column chrom atograph i que 1 constituted by a tubular glass cylinder, in the example of a height of the order of 80 cm and a capacity of the order of 1 liter of resin.
- This column is provided, at the bottom, 'a fritted disc 2 which supports an exchange resin bed ion 3 which extends over the greater part of the height of the column.
- This resin is a "Bayer Lewatit K 2431" resin which is a strong macroporous acid resin with a polystyrenic backbone, functionalized by sulfonic groups. Its size is between 0.3 and 1.25 mm.
- Column 1 includes an inlet 4 for mixing esters to be separated, which opens just above the resin bed.
- This conduit equipped with a metering pump 5, is connected to a reservoir 6 containing the mixture of esters.
- column 1 is closed by a cover 7 which is crossed by an inlet duct 8 connected by means of a multi-way valve system 9 and supply pumps, to a series of tanks:
- a distilled water tank 10 a reservoir 11 containing an aqueous solution of HCl, 2N,. a reservoir 12 containing an aqueous solution of Ag NO3, 05N,
- the column 1 is connected to a recovery duct 16 equipped with a multi-channel system 17 opening either into a tank for recovering washing effluents 18, or into a tank 19 for recovery of Ag NO- j and HNO3, ie in reservoirs 20, 21 and 22 for collecting eluates: methanol and saturated and mono-unsaturated esters, ethanol and di-unsaturated esters, final elution solvent and poly- esters Mé you res.
- the resin is washed with distilled water 10 until the water leaving the column is perfectly clear. Then ethanol 14 is percolated through the bed in order to rid the resin of organic impurities.
- a volume of the HCl solution 11 equal to 2 times the volume of the resin is passed through the bed in order to guarantee total permutation of the active sites by H + protons.
- the distilled water is percolated again to remove the residual HCl.
- the resin of the bed can then be permuted in Ag + form by percolating the solution 12 of Ag NO3.
- a volume of Ag NO-z solution, eight times greater than the volume of resin, is caused to percolate in order to obtain a 100% permutation in Ag + form.
- the completeness of the permutation is checked, on the one hand, by potentiometric measurement of the solution of Ag NO3 leaving the column, on the other hand, by micro-analysis of a resin sample.
- a volume of mixture of esters 6 is then admitted to the resin bed equal to 1/20 of the volume of resin (50 cm for 1 liter of resin); this mixture which opens out through the conduit 4 is deposited at the head of the bed and permeates its upper part.
- the next step is a methanol elution step which consists in percolating a volume Vm of methanol through the bed; this volume which depends on the mixture of esters to be treated is between 0.5 and 2 times the volume of resin.
- Vm volume which depends on the mixture of esters to be treated
- the eluate is recovered in the corresponding tank 20.
- the separation is followed over time by gas chromatographic analysis, carried out on samples of eluates.
- the column is then subjected to an ethanol elution step which consists in percolating through the bed a volume V of ethanol of between 2.5 and 4.5 times the volume of resin.
- the column is finally subjected to a final elution step by means of the mixture of solvents, contained in the reservoir 15.
- a volume V- of this mixture comprised between 1.5 and 4 times the volume of resin, is caused to percolate across the bed.
- the eluates respectively stored in the tanks 20, 21 and 22 are subjected to evaporation in the device 24 which makes it possible to separate the solvent and the esters, the solvent being recycled to the corresponding tank 13, 14, 15.
- esters obtained were subjected to gas chromatographic analyzes in order to determine their purity.
- the mixture of esters treated in this example comes from an oil extracted from crushed pastel seeds, the extraction being carried out in a known manner in an apparatus of the "Soxhlet” type using hexane, at reflux temperature of this compound. After 6 hours, an orange-yellow oil with an acidity of 0.8% (eri weight of free fatty acid) is obtained.
- This oil is neutralized by adding an equal weight of anhydrous methanol with catalysis by "Lewatit 24.31" resin in acid form, used in an amount equal to 10% of the weight of oil; the reaction is carried out at 65 ° C for 3 hours with stirring. After separation of the resin and evaporation of the residual methanol, the mixture of oil and methyl esters obtained is transesterified by addition 20% methanol based on the weight of the mixture and 0.25% soda (by weight), at a temperature of 65 ° C for 2 hours.
- methyl esters and glycerins are separated by decantation and the mixture of methyl esters is treated in accordance with the invention in the installation described above under the following conditions: - volume of esters to be separated: 45 ml or 39 g,
- Vf of the final elution solvent equal to 2 liters (2 times the volume of resin
- esters of saturated and monounsaturated fatty acids palmitate, aleatory, eicosenoate, erucate.
- the process makes it possible to obtain, with a yield greater than 98%, linoleate and o-linolenate of remarkable purity.
- the sysimbre oil used is a commercially available oil, supplied by the company "Berdoues (Toulouse)". This oil has 0.84% acidity. It is neutralized and transesterified as in Example 1.
- the process of the invention is applied to the mixture of esters obtained (after decantation of the glycerin) under the following conditions:
- esters of saturated and monounsaturated fatty acids palmitate, oleate, eicosenoate, erucate.
- Example 3 is similar to Example 3 but using as a final elution solvent a mixture of 1,1,2-trichloro-1,2-trioro-2,1,2 ethane (90% by weight) and hexene-1 ( 10%) (same volumes of solvents as before). The results are identical to the previous ones. It should be noted that the presence of the vector solvent with low boiling point further lowers the cost of implementing the process.
- the borage oil used was supplied by the " departments Berdoues". This oil has 3.8% acidity. It is neutralized and transesterified as in Example 1.
- the process of the invention is applied under the following conditions: - volume of esters to be separated: 45 ml, ie 40 g,
- esters of saturated and monounsaturated fatty acids palmitate, oleate, eicosenote, trace amount of erucate.
- the process of the invention is applied under the following conditions: - volume of esters to be separated: 45 ml, ie 40 g,
- esters of saturated and monounsaturated fatty acids palmitate, oleate.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8910284A FR2650274B1 (fr) | 1989-07-27 | 1989-07-27 | Procede de fractionnement d'un melange d'esters d'acides gras |
FR89/10284 | 1989-07-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1991001965A1 true WO1991001965A1 (fr) | 1991-02-21 |
Family
ID=9384309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1990/000548 WO1991001965A1 (fr) | 1989-07-27 | 1990-07-19 | Procede de fractionnement d'un melange d'esters d'acides gras |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0484435A1 (fr) |
AU (1) | AU6270390A (fr) |
FR (1) | FR2650274B1 (fr) |
WO (1) | WO1991001965A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965755A (en) * | 1993-10-12 | 1999-10-12 | Agrigenetics, Inc. | Oil produced from the Brassica napus |
WO2014108686A1 (fr) * | 2013-01-09 | 2014-07-17 | Basf Pharma (Callanish) Limited | Procédé de séparation multi-étapes |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10224937A1 (de) | 2001-06-05 | 2002-12-12 | Celanese Ventures Gmbh | Festphasen-Extraktionsverfahren zur Gewinnung hochreiner ungesättigter Verbindungen bzw. Derivate dieser Verbindungen |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4282164A (en) * | 1980-01-02 | 1981-08-04 | The Procter & Gamble Company | Fractionation of alkylcarboxylate mixtures |
-
1989
- 1989-07-27 FR FR8910284A patent/FR2650274B1/fr not_active Expired - Lifetime
-
1990
- 1990-07-19 EP EP19900912302 patent/EP0484435A1/fr not_active Ceased
- 1990-07-19 AU AU62703/90A patent/AU6270390A/en not_active Abandoned
- 1990-07-19 WO PCT/FR1990/000548 patent/WO1991001965A1/fr not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4282164A (en) * | 1980-01-02 | 1981-08-04 | The Procter & Gamble Company | Fractionation of alkylcarboxylate mixtures |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965755A (en) * | 1993-10-12 | 1999-10-12 | Agrigenetics, Inc. | Oil produced from the Brassica napus |
US6169190B1 (en) | 1993-10-12 | 2001-01-02 | Agrigenetics Inc | Oil of Brassica napus |
WO2014108686A1 (fr) * | 2013-01-09 | 2014-07-17 | Basf Pharma (Callanish) Limited | Procédé de séparation multi-étapes |
EP3170543A1 (fr) * | 2013-01-09 | 2017-05-24 | BASF Pharma (Callanish) Limited | Procédé de séparation en plusieurs étapes |
US10179759B2 (en) | 2013-01-09 | 2019-01-15 | Basf Pharma (Callanish) Limited | Multi-step separation process |
US10214475B2 (en) | 2013-01-09 | 2019-02-26 | Basf Pharma (Callanish) Limited | Multi-step separation process |
US10723973B2 (en) | 2013-01-09 | 2020-07-28 | Basf Pharma (Callanish) Limited | Multi-step separation process |
Also Published As
Publication number | Publication date |
---|---|
EP0484435A1 (fr) | 1992-05-13 |
FR2650274A1 (fr) | 1991-02-01 |
FR2650274B1 (fr) | 1991-10-18 |
AU6270390A (en) | 1991-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1177012A (fr) | Procede de production d'alcools deshydrates utilisables comme composants d'un carburant pour moteur | |
EP0965562B1 (fr) | Procédé et installation pour la fabrication d'une solution aqueuse de peroxyde d'hydrogène et solution aqueuse de peroxyde d'hydrogène | |
DE3501761A1 (de) | Verfahren zur vorveresterung freier fettsaeuren in rohfetten und/oder -oelen | |
WO2004016106A1 (fr) | Procede d'obtention d'un insaponifiable d'avocat riche en lipides furaniques | |
FR2641532A1 (fr) | Procede pour la preparation d'esters de l'acide (beta)-hydroxybutyrique | |
FR2700536A1 (fr) | Procédé perfectionné pour oligomériser les acides et les esters polyinsaturés. | |
CA1129625A (fr) | Procede de separation de l'acide sulfurique et de l'effluent contenant du sulfoxyde, produit lors de la reaction du bioxyde de soufre, de l'oxygene et de l'eau sur des paraffines, en presence de lumiere uv | |
EP0454430A1 (fr) | Méthode pour la purification de composés aliphatiques poly-insaturés et appareil pour cela | |
WO1991001965A1 (fr) | Procede de fractionnement d'un melange d'esters d'acides gras | |
EP0021952B1 (fr) | Procédé pour la préparation de l'alcool périllique et de ses dérivés | |
NO133800B (fr) | ||
EP0037349B1 (fr) | Procédé de préparation d'O,O-diméthyl-phosphorodithioate de mercaptosuccinate d'ethyl (malathion(R)) | |
CA2516639A1 (fr) | Purification de 1,3-propanediol par distillation | |
NL8501778A (nl) | Werkwijze ter behandeling van natuurlijke olien en vetten. | |
JPS6058211B2 (ja) | β−フェニルエチルアルコ−ルの精製方法 | |
CA2522691C (fr) | Procede de preparation de l-iditol | |
US6207867B1 (en) | Method for purifying β-phenylethyl alcohol | |
FR2617499A1 (fr) | Procede d'extraction des huiles essentielles de plantes aromatiques et produits obtenus | |
D'souza | The importance of glycerol in the fatty acid industry | |
JPH0120137B2 (fr) | ||
JPH0735366B2 (ja) | カロチン含有濃縮物の製造方法 | |
US2573890A (en) | Separation of tall oil components | |
BE519660A (fr) | Procédé pour la décoloration des plastifiants et l'amélioration de leur stabilité thermique | |
JPS5967245A (ja) | 高度不飽和脂肪酸エステルの濃縮分離方法 | |
FR2741065A1 (fr) | Procede de preparation du sclareol comprenant une etape de chromatographie d'adsorption sur silice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BG BR CA FI HU JP KP KR NO RO SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1990912302 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1990912302 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWR | Wipo information: refused in national office |
Ref document number: 1990912302 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1990912302 Country of ref document: EP |